Bergen Brunswig’s Profit Drops

Bergen Brunswig Corp., an Orange supplier of pharmaceuticals and health care products, reported a profit of $10.3 million, or 28 cents a share, for its latest fiscal quarter. That was down 13% from earnings of $11.9 million, or 32 cents a share, for the same period a year earlier. Revenue for the company’s first quarter, which ended Dec. 31, rose 13% to $1.8 billion from $1.6 billion. As previously announced, Bergen Brunswig has changed the close of its fiscal year from Aug. 31 to Sept. 30. As a result of the change, the month of September, 1993, is not included in operating results for either fiscal 1993 or fiscal 1994, the company said.